Regional lymph node metastases; a singular manifestation of the process of clinical metastases in cancer: Contemporary animal research and clinical reports suggest unifying concepts

Annals of Surgical Oncology

Volumn 14, Issue 6, 2007, Pages 1790-1800

  Cady, Blake ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; CORRELATION ANALYSIS; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; LUNG CANCER; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; LYMPHOCYTE; MELANOMA; NONHUMAN; RECTUM CANCER; SENTINEL LYMPH NODE BIOPSY; STOMACH CANCER;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS;

EID: 34249951148     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9234-2     Document Type: Article

References (76)

1. Irjala H, Alanen K, Grenman R, et al. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 2003; 63(15):4671-6
2. Solomayer E, Diel I, Meyberg G, et al. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastases. Br Cancer Res Treat 2000; 59:271-278
3. Yang J, Mani S, Donaher J, et al. Twist, A Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis. Cell 2004; 117:927-939
4. Clark E, Golub T, Lander E, Hynes R. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406:532-535
5. Minn A, Gupta G, Siegel P, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436:518-524
6. Kang Y, Siegel P, Shu W, et al. A multigene program mediating breast cancer metastasis to bone. Cancer Cell 2003; 3:537-549
7. Gervasoni JE, Jr., Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am 2000; 80(6):1631-73
8. Halsted W. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907; 46:1-9
9. Moynihan G. The surgical treatment of cancer of the sigmoid flexure and rectum. Surg Gynecol Obstet 1908; 6:463-6
10. Neuhaus S, Clark M, Thomas J. Dr. Herbert Lumley Snow, MD MRCS (1847-1930): The Original Champion of Elective Lymph Node Dissection in Melanoma. Annals of Surgical Oncology 2004; 11(9):875-878
11. Taneja C, Cady B. Decreasing role of lymphatic system surgery in surgical oncology. J Surg Oncol 2005; 89(2):61-6
12. Kampmeier O. Evolution and Comparative Morphology of the Lymphatic System: Charles C. Thomas, 1969
13. Cady B. Is axillary lymph node dissection necessary in routine management of breast cancer? No. Principles and Practice of Oncology 1998; 12:1-12
14. Miyasaka M, Tanaka T. Lymphocyte Trafficking Across High Endothelial Venules: Dogmas and Enigmas. Nature Rev 2004; 4:360-370
15. Fisher B, Fisher E. Transmigration of Lymph Nodes by Tumor Cells. Science 1966; 152(3727):1397-1398
16. Huang RR, Wen DR, Guo J, et al. Selective Modulation of Paracortical Dendritic Cells and T-Lymphocytes in Breast Cancer Sentinel Lymph Nodes. Breast J 2000; 6(4):225-232
17. Clarke J, Cha J, Walsh M, et al. Dendritic cells as therapeutic adjuncts in surgical disease. Surgery 2005; 138(5):844-50
18. Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BB. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001; 192(3):399-409
19. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466
20. Chao C, Wong SL, Tuttle TM, et al. Sentinel lymph node biopsy for breast cancer: improvement in results over time. Breast J 2004; 10(4):337-44
21. Cady B. Fundamentals of Contemporary Surgical Oncology: Biologic Principles and the Threshold Concept Govern Treatment and Outcomes. J Am Coll Surg 2001; 192(6):777-792
22. Cady B. Simplification of Breast Cancer Surgery. Annals of Surgical Oncology 2005; 12(1):6-8
23. Fidler I. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Reviews 2003; 3:1-6
24. Tang Y, Zhang D, Fallavollita L, Brodt P. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res 2003; 63(6):1166-71
25. Fidler IJ. The organ microenvironment and cancer metastasis. Differentiation 2002; 70(9-10):498-505
26. LeBedis C, Chen K, Fallavollita L, et al. Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 2002; 100:2-8
27. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7(2):192-8
28. Espana L, Fernandez Y, Rubio N, et al. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res Treat 2004; 87(1):33-44
29. Brodt P, Fallavollita L, Khatib AM, et al. Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit. J Biol Chem 2001; 276(36):33608-15
30. Khatib AM, Fallavollita L, Wancewicz EV, et al. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 2002; 62(19):5393-8
31. Onn A, Isobe T, Itasaka S, et al. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 2003; 9(15):5532-9
32. Arap W, Kolonin M, Trepel M, et al. Steps toward mapping the human vasculature by phage display. Nat Med 2002; 8(2):121-127
33. Charo I, Ransohoff R. The Many Roles of Chemokines and Chemokine Receptors in Inflammation. N Engl J Med 2006; 354(6):610-621
34. Cady B, Jenkins RL, Steele GD, Jr., et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998; 227(4):566-71
35. Vezeridis M, Moore R, Karakousis C. Metastatic patterns in soft-tissue sarcomas. Arch Surg 1983; 118:915
36. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235(4):533-9
37. Tarin D, Price JE, Kettlewell MG, et al. Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. Br Med J (Clin Res Ed) 1984; 288(6419):749-51
38. Cady B. Presidential address: Beyond risk groups-A new look at differentiated thyroid cancer. Surgery 1998; 124(6):947-957
39. Modlin I, Lye K, Kidd M. A 5-decade Analysis of 13,715 carcinoid tumors. Cancer 2003; 97(4):934-959
40. Mullen J, Wang H, Yao J, et al. Carcinoid Tumors of the Duodenum. Surgery In Press 2005
41. Samani AA, Brodt P. The Receptor for the Type I Insulin-Like Growth Factor and its Ligands Regulate Multiple Cellular Functions that Impact on Metastasis. Surg Clin North Am 2001; 10(2):289-312
42. Nathanson S. Insights into the Mechanisms of Lymph Node Metastasis. Cancer 2003; 98(2):413-423
43. Cady B. Basic principles in surgical oncology. Arch Surg 1997; 132(4):338-46
44. Elias D, Liberale G, Vernerey D, et al. Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect. Ann Surg Oncol 2005; 12(11):900-909
45. Chagpar A, Middleton LP, Sahin AA, et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 2005; 103(8):1581-6
46. Wieder R. Insurgent micrometastases: sleeper cells and harboring the enemy. J Surg Oncol 2005; 89(4):207-10
47. Meng S, D. T, Frenkel EP, et al. Circulating Tumor Cells in Patients with Breast Cancer Dormancy. Clin Cancer Res 2004; 10:8152-8162
48. Diel I, Kaufinann M, Costa S. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996; 8:1652-58
49. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000; 342(8):525-33
50. Braun S, F.D. V, B. N, et al. A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer. N Engl J Med 2005; 353:793-802
51. Bonavina L, Soligo D, Quirici N, et al. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery 2001; 129(1):15-22
52. O'Sullivan G, Sheehan D, Clarke A, et al. Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 1999; 116(3):543-8
53. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000; 70(12):1747-51
54. Buell JF, Trofe J, Hanaway MJ, et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 2001; 130(4):660-6; discussion 666-8
55. MacKie RM, Reid R, Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med 2003; 348(6):567-8
56. Page DL, Anderson TJ, Carter BA. Minimal solid tumor involvement of regional and distant sites: when is a metastasis not a metastasis? Cancer 1999; 86(12):2589-92
57. Naumov GN, MacDonald IC, Weinmeister PM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002; 62(7):2162-8
58. Fisher B, Fisher ER. Experimental evidence in support of the dormant tumor cell. Science 1959; 130:918-9
59. Chambers AF, Naumov GN, Varghese HJ, et al. Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 2001; 10(2):243-55, vii
60. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 1994; 12(10):2229-34
61. Soga W, Ohyama S, K M. A statistical evaluation of advancement in gastric cancer surgery with special reference to the significance of lymphadenectomy for cure. World J Surg 1988; 12:398
62. Stetler-Stevenson W. (2005) Invasion and Metastases. 7th ed. Philadelphia: Lippincott Williams & Wilkins.
63. Zurrida S, Orecchia R, Galimberti V, et al. Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology Group. Ann Surg Oncol 2002; 9(2):156-60
64. Louis-Sylvestre C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004; 22(1):97-101
65. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004; 240(3):462-8; discussion 468-71
66. Cady B. A Randomized Trial Comparing Axillary Dissection to No Axillary Dissection in Elderly Patients with T1N0 Breast Cancer - Results After Long-term Follow-up. Ann Surg 2005; 242(1):7-9
67. Mendez J, Fey J, Cody H, et al. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology? Ann Surg Oncol 2005; 12(1):24-28
68. Coburn NG, Chung MA, Fulton J, Cady B. Decreased breast cancer tumor size, stage, and mortality in rhode island: an example of a well-screened population. Cancer Control 2004; 11(4):222-30
69. Heimann R, Munsell M, McBride R. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size? Cancer J 2002; 8(3):276-81
70. Norden T, Thurfjell E, Hasselgren M, et al. Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer 1997; 33(4):624-8
71. Bucchi L, Barchielli A, Ravaioli A, et al. Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer 2005; 92(1):156-61
72. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet Vol. 354, 1999. pp. 896-900
73. Group TSOSSE. Reduction in Breast Cancer Mortality from Organised Service Screening with Mammography: Further confirmation with Extended Data and New Analytic Methods. Cancer Epidemiology, Biomarkers and Prevention In press
74. Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003; 361(9367):1405-10
75. Tabar L, Chen HH, Yen MF, et al. Mammographic Tumor Features Can Predict Long-term Outcomes Reliably in Women with 1-14-mm Invasive Breast Carcinoma. Cancer 2004; 101(8):1745-1759
76. Cabioglu N, Hunt KK, Buchholz TA, et al. Improving Local Control in Breast-Conserving Therapy - A 27-Year Single-Institution Experience. Cancer 2005; 104(1):20-29